TLR1 variants N248S and I602S have been described associated with leprosy, but different results were found. Here, we performed both a case-control and family-based studies followed by replication in two case-control samples from Our results suggest that TLR1 248S is associated with leprosy risk, consistent with its hypo-immune regulatory function.
Introduction

Interaction of bacterial, fungi and viral components with Pattern Recognition
Receptors (PRRs), such as Toll-like receptors (TLRs), activates the NF-kB pathway, triggers inflammation and initializes events of the adaptive immune response [1] [2] [3] . It has been suggested that subtle genetic variations in relevant genes of the innate and adaptive immune responses are regulating every step of the host-pathogen interaction [4, 5] , while low genetic variability of M. leprae [6, 7] suggests that host genetic factors may be of major influence towards M. leprae infection and progression of leprosy.
In this scenario, pathways triggered by PRRs, such as TLR1 and NOD2, are key to define leprosy outcome. TLR1 and TLR2 cooperate to sense mycobacterial triacylated lipoproteins while the activation of TLR1/TLR2 dimer by M. tuberculosis lipoproteins triggers the TLR-mediated antimicrobial response, reducing the viability of intracellular bacilli [8, 9] . Polymorphisms at MRC1 and NOD2 genes have been associated with increased leprosy risk [10] [11] [12] . Likewise, polymorphisms located at TLRs genes were repeatedly associated with leprosy per se and leprosy reactions [13] [14] [15] [16] [17] [18] . The S allele of I602S (T1805G) polymorphism has been associated with leprosy resistance and to the impairment of molecule expression at the cell surface, NF-B signaling and production of pro-inflammatory cytokines [13, 15, 19] . However, I602S was not found associated with the disease in a population from Bangladesh [17] . Also, the same study described the 248SS genotype of another non-synonymous SNP, N248S (G743A), associated with leprosy risk [17] . Interestingly, allele N of TLR1 N248S has been associated with TLR1 decreased expression or lower induction of cytokines [2, 20] . Here we 
Materials and Methods
Subjects and Study Design
We performed a case-control study in a population from Bauru, a city in São Paulo state, at Lauro de Souza Lima Institute (ILSL) and a family-based study from Almenara population, Minas Gerais state. Then, we applied a stepwise replication approach to include case-control studies from Rio de Janeiro (Rio), Fiocruz and from Rondonópolis (ROO), Mato Grosso state. In each casecontrol cohort, unrelated blood donors from the same endemic area as patients were recruited as controls. The familial sample included households of leprosy cases, composed originally by trios formed by the index case and their biological parents. For those in which one of parents was not present, siblings were included to infer the genotype of the absent parent. All patients were classified according to the Ridley and Jopling [22] , and also according to the 1998 World Health Organization (paucibacillary or multibacillary). All subjects were ethnically classified as caucasoids, mestizoes or blacks, according to morphological characteristics of both the individual as well as his/her family.
General characteristics of all samples used in these studies are presented in Supplementary table 1. For functional studies, a group of 24 healthy female individuals with a mean age of 45 years was selected among staff of the ILSL, in order to represent individuals carrying 248NN genotype (n=9), 248NS (n=9) and 248SS (n=6). A and 248SS (n=3). All individuals enrolled in the current study signed an informed consent. The study protocol was approved after revision by local ethical boards of involved institutions.
DNA extraction and SNP genotyping
Genomic DNA was extracted from frozen blood samples by the salting out method. N248S polymorphism (rs4833095, A743G) was genotyped by real-time PCR allelic discrimination and reactions were carried out using a TaqMan Assay from Applied Biosystems (Assay ID: C__44103606_10) according to manufacturer's instructions. The I602S SNP (rs5743618, T1805G) was genotyped using nested PCR, with conventional reaction performed as described by Johnson et al., 2007 [13] . Then, the amplicons were used for realtime PCR reactions with TaqMan Design Assay provided by Applied Biosystems. All real-time reactions were conducted using the StepOne Plus Real-Time PCR System, and the genotyping was based on allelic discrimination, through the StepOne 2.1 software (Applied Biosystems).
Sequencing
In order to identify other possibly associated SNPs at the TLR1 coding region antibiotics. Cultures were kept at 37°C in a humidified 5% CO2 atmosphere for 18h (Bauru samples), 24h or 72h (Rio samples). After this, the cell suspension was harvested and centrifuged. In all samples, the supernatant was kept at -80°C for cytokine measurements while only in Bauru samples, the cell pellet was resuspended in the residual volume and evaluated by flow cytometry. 
Comparative modeling and Molecular Dynamics
The 8 haplotypes formed by polymorphisms at positions N248S, H305L and P315L (NHL, NHP, NLL, NLP, SHL, SHP, SLL, and SLP) were incorporated into the crystal structure (PDB code 2Z7X), that corresponds to NHP haplotype, by using the Pymol program [24] . The simulations were run on Gromacs 4.5.4.
[25]. The systems were energy-minimized using periodic boundary conditions to fit the atomic positions to the GROMOS96 force field [26] . The net charge of the 
Statistical Analyses
For case-control samples, all statistical analyses (genotypic, allelic and haplotypic with and without adjustment for the covariates) were performed as previously described [23, 27] . SNPs at TLR1 were tested for deviations from
Hardy-Weinberg Equilibrium (HWE) in control groups, and were in agreement in all populations studied. We evaluated if allelic dose and their OR values were directly proportional (allele-dose effects) by the Cochran-Armitage trend test.
Linkage disequilibrium analysis between markers was performed through r 2 statistics in the control group. All analyses were performed using the statistical software R for Windows version 2.14.0 [28] , using "genetics" [29] , "haplo.stats" [30] and "coin" [31] packages.
In the family-based study, a Transmission Disequilibrium Test (TDT) was performed, based on counts of transmission of a marker allele from heterozygous parents to affected child [32] . We obtained the number of transmitted and non-transmitted alleles using the 'tdthap' package from R [33] .
The analysis of the family study was conducted in software FBAT -Family Based Association Test [34] . 
Results
The N248S SNP is associated with leprosy
The frequencies of genotypes, alleles and minor allele carriers of N248S and I602S SNPs at the Bauru population are shown in (Figure 1 ). Then, we performed a N248S-I602S haplotypic analysis (Table 2) . Using N248/602S
haplotype as baseline, the combination S248/I602 was, in the same direction, associated with leprosy susceptibility (OR corrected =1.26; p=0.03). Furthermore, similar to that seen previously in Indians, the arrangement 248S/602S was virtually absent (frequency <0.01) in Brazilians (Table 2 ).
In the family-based replication study from Almenara, the TDT revealed that the S248 allele was over-transmitted to affected individuals (z=2.15, p=0.05, Supplementary table 2), confirming the association with susceptibility to leprosy per se. The familial sample was tested for I602S, and despite the 602S allele has been under-transmitted to affected individuals, the association was marginally significant (data not shown, z=2.16, p=0.06). In Almenara sample, N248S and I602S also are in moderate LD (r 2 = 0.55) and consistently, the 248S/I602 haplotype was associated with risk to leprosy, replicating the casecontrol result (Table 2 ).
Considering the relevant genetic effect of N248S observed in two populations, we turned our focus to this SNP, and proceeded with a second replication Additionally, we performed a systematic review of the literature for association studies between N248S and leprosy per se that could qualify for a metaanalysis, but the search resulted in only one eligible study, a case-control performed by Schuring and colleagues [17] in Bangladesh (Supplementary   table 2 ). The meta-analysis showed a risk pooled OR (1.22,p<0.0001), supporting the association between 248S and susceptibility to leprosy per se (Supplementary figure 1) .
The N248S SNP is associated with hypo-responsive immune activation
We then investigated the effect of the N248S variation over TLR1 function. As presented in Figure 2A , we evaluated the expression of TLR1 in monocytes 3) than non-carriers (ratio= 0.6) ( Figure 2B ). Yet, the log(TNF/IL10) ratio was not different when we compared 602S carriers (602IS/SS) and non-carriers (602II) (data not shown). The IL-6 levels in the supernatant were also stratified by N248S and I602S, but the differences were not significant for either (data not shown). We also performed an independent sample recruitment of healthy subjects from Rio. Similarly to the results from the Bauru sample, the log(TNF/IL10) ratio was significantly lower (p=0.01) in 248S carriers (ratio= 0.1) than in non-carriers (ratio= 0.6), but significance was reached only when BCG Moreau was used as stimulus ( Figure 2C ). Figure 3B ).
Discussion
The most important finding of our study is that TLR1 N248S SNP controls responses to mycobacteria and contributes to leprosy susceptibility. Also, N248S regulates immune responses to BCG stimulation, which is crucial towards understanding of customization of vaccines among "hypo-responsive" individuals.
We found a very reliable genetic association effect of TLR1 248S with leprosy susceptibility. This genetic finding was obtained through two replications of an initial positive association signal in which 248S variation were found at increased risk of developing leprosy in case-control and familial-based studies.
The association of the SS genotype and risk of leprosy was previously reported in a Bangladesh population [17] . This paper was added to our sample for metaanalysis, after our systematic review; as a result, the study reached a total of 4,207 individuals enrolled, and a pooled OR of 1.22 (p<0.0001). Curiously, allele 248S may be involved with susceptibility control of other mycobacterial diseases like tuberculosis in African-Americans that was also associated the 248S allele [40] .
The present findings implicating N248S SNP along with the absence of association observed between I602S and leprosy in our study is intriguing because other studies conducted among Turkeys [13] and Indians [18] implicated 602S as associated with leprosy protection. While few papers have provided a detailed analysis of other SNPs in the locus in leprosy studies, in TB, both the 602S allele [40] and the 602I allele were associated with risk [20] . Also, reanalysis of genome-wide study did not find I602S associated with leprosy among the Chinese [41] . Maybe the heterogeneous distribution of I602S frequencies in different regions of the world, and the changes in LD could explain differential associations in the locus. In Caucasians [2] the r 2 between N248S and I602S was around 0.80, whereas in Indians the r 2 is reported to be around 0.08 [18] . Yet, the arrangement of the 248S/602S haplotype was virtually absent in our study and in Indians, although among Euro-Americans this haplotype has a frequency of 7% [19] (Table 2) .
Even though we have evaluated populations from different geographical regions of Brazil, we calculated the linkage disequilibrium between N248S and in a way that we could not rule out that S506S is the functional SNP since other synonymous SNPs have been associated with a myriad of diseases [42] . In this regard, it is likely that different genotypes contribute to the same phenotype, i.e leprosy outcome.
Given our results, we turned our focus to the N248S effect, since it was genetically and biologically associated with leprosy by independent results.
However, additional studies still need to be conducted to understand the contribution of the genetic effect of I602S with leprosy in the Brazilian population, to evaluate the LD profile of an extended region in the locus, since more thorough study of the entire block of TLR1 in different populations in associations with diseases is still missing.
Overall, our functional and molecular dynamics results indicates that N248S is indeed has a important biological role for a N to S aminoacid change.
To advance on the understanding of the biological effect underlying the strong evidence for genetic association between N248S and leprosy, we investigated the functional profile of PBMCs obtained from carriers and non-carriers of allele "S". Unlike previously reported [20] , the expression of TLR1 was detectable in PBMCs surface of both S carriers and non-carriers. But, the investigation of genotype/phenotype correlation revealed that cells from 248S carriers had a lower TNF/IL10 ratio when mycobacterial stimulation was used. Interestingly, 248S were hypo-responsive for every BCG strain tested; however, the effect only reached statistical significance when BCG Moreau was used. It has been reported that host-pathogen joint effects on susceptibility to mycobacterial infections [43, 44] . Also, the observation suggests the existence of specific hostpathogen interactions impacting on vaccine response. Curiously, a specific agonist of TLR1 induced similar cytokine production between the two genotype groups. This observation raises the discussion on whether a possible approach could be to use the specific TLR1 agonists as adjuvant in addition to BCG vaccination, which could contribute to improve immune response in susceptible individuals. Recently, TLR pathway variations have been related with altered in vivo immune response to BCG after newborn vaccination, suggesting novel adjuvant vaccine strategies [45] . The use of TLRs ligands has already been studied to potentiate vaccine-induced responses to provide not only prophylactic, but therapeutic protection against infectious diseases [46, 47] .
Polymorphism N248S, as well as H305L and P315, are located in the extracellular domain of TLR1, more specifically at a leucine-rich repeat (LRR) [48] , which is responsible to define specificity towards different lipopeptides agonists [38] . Interestingly, our simulations by molecular dynamics revealed, for 
